Leng Han

Texas A&M University Health Science Ctr

$4,260,272

Attributed

$4,260,272

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $936.3K · FY2021–25

$1M$750K$500K$250K$0

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$4,260,272 · 3

By mechanism

R01$3,954,021 · 2

R03$306,251 · 1

Top collaborators

No co-investigators on record.

Most similar at Texas A&M University Health Science Ctr

Same institution · by research overlap

Chendil Damodaran$13,213,142
Roger C Garcia$38,132

Others in their field

Other Emerging Leaders on “Malignant Neoplasms”

Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
Martha Hering · Westat, Inc.$57,098,843

Research focus

Malignant NeoplasmsTherapeutic TargetMultiomic DataMolecularGenetic VariantUser-FriendlyQuantitative Trait LociData ResourceCommunitiesPharmaceutical PreparationsSamplingCancer TypeThe Cancer Genome AtlasResearch PersonnelResponsePlayPrognosticData PortalMethylationBiological MarkersClinically RelevantLarge Scale DataGenomicsGenome Editing